ARMISTICE CAPITAL LLC 13D and 13G filings for Dermata Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 3:26 pm Purchase |
2025-03-31 | 13G | Dermata Therapeutics, Inc. DRMA |
ARMISTICE CAPITAL LLC | 1,065,076 9.990% |
788,654 (+285.31%) |
Filing |
| 2025-02-14 5:41 pm Purchase |
2024-12-31 | 13G | Dermata Therapeutics, Inc. DRMA |
ARMISTICE CAPITAL LLC | 276,422 9.990% |
90,211 (+48.45%) |
Filing |
| 2024-11-14 5:07 pm Purchase |
2024-09-30 | 13G | Dermata Therapeutics, Inc. DRMA |
ARMISTICE CAPITAL LLC | 186,211 9.990% |
186,211 (New Position) |
Filing |